Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Review

Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors

Baohong Zhao1 and Lionel B Ivashkiv12*

Author Affiliations

1 Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USA

2 Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Science, New York, NY 10021, USA

For all author emails, please log on.

Arthritis Research & Therapy 2011, 13:234  doi:10.1186/ar3379


See related review by Braun and Zwerina, http://arthritis-research.com/content/13/4/235

Published: 28 July 2011

Abstract

Bone remodeling in physiological and pathological conditions represents a balance between bone resorption mediated by osteoclasts and bone formation by osteoblasts. Bone resorption is tightly and dynamically regulated by multiple mediators, including cytokines that act directly on osteoclasts and their precursors, or indirectly by modulating osteoblast lineage cells that in turn regulate osteoclast differentiation. The critical role of cytokines in inducing and promoting osteoclast differentiation, function and survival is covered by the accompanying review by Zwerina and colleagues. Recently, it has become clear that negative regulation of osteoclastogenesis and bone resorption by inflammatory factors and cytokines, downstream signaling pathways, and a newly described network of transcriptional repressors plays a key role in bone homeostasis by fine tuning bone remodeling and restraining excessive bone resorption in inflammatory settings. In this review we discuss negative regulators of osteoclastogenesis and mechanisms by which these factors suppress bone resorption.